Cybin Inc (HELP) Stock Analysis
Verdict: AVOID
CYB003 pipeline potential is offset by cash burn of C$133.8M and imminent dilution risk within 14 months.
Investment score: 32/100
Analysis as of
Is Cybin Inc stock worth reviewing? AI model thesis
Cybin Inc is a clinical-stage biopharmaceutical developing psychedelic-based treatments (CYB003, CYB004). With zero commercial revenue, C$133.8M in annual cash burn against C$157.8M in cash balance, and consistent earnings misses, the AI model assigns an AVOID rating.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 30/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Cybin Inc opportunities and risks
What speaks for HELP
- Phase 3 clinical trial progress for CYB003 in Major Depressive Disorder
What speaks against HELP
- Accelerating free cash flow burn of C$133.8M leaves ~14 months of cash runway
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| HELP | n/a | 0.0x | n/a | 0.0% | 0.0% | -47.5% |
| HALO.NE | n/a | 0.3x | n/a | 12.3% | -261.5% | -304.5% |
| CANB.V | n/a | 0.2x | 215.0x | 44.2% | -13.6% | -139.2% |
| CPMD | n/a | 1.0x | n/a | -88.8% | -666.2% | 15.6% |
| CVGR.CN | n/a | 0.0x | n/a | 0.0% | 0.0% | -21.8% |
| Peer median | n/a | 0.3x | n/a | 6.2% | -137.5% | -80.5% |
Frequently asked questions about Cybin Inc (HELP)
Is HELP stock a good investment?
The cached TradeMates AI model rates Cybin Inc as AVOID with an investment score of 32/100. Cybin Inc is a clinical-stage biopharmaceutical developing psychedelic-based treatments (CYB003, CYB004). With zero commercial revenue, C$133.8M in annual cash burn against C$157.8M in cash balance, and consistent earnings misses, the AI model assigns an AVOID rating. This is algorithmic model output, not personal investment advice.
Is HELP stock a buy?
The TradeMates model verdict for HELP is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.